Healthcare
NYC public schools to resume in-person learning in September
New York City Mayor Bill de Blasio appeared on MSNBC’s Morning Joe on Monday to announce that public schools will resume in-person learning this fall. For the last year and a half, schools across the city have opened and closed more than once.
“That’s the news I think parents, kids, everyone has been waiting for, to know we’re going to be back, strong, ready, safe,” de Blasio said. Because, he pointed out, roughly 8 million in the city have received the vaccine. Next, students will no longer have a remote option. Currently about 60% of the 1 million school-aged children are attending class remotely.
“You can’t have a full recovery without full-strength schools, everyone back sitting in those classrooms, kids learning again,” de Blasio went on. “And that’s what’s going to happen in September.”
De Blasio said New York schools are “much safer than any other place in the city.” This comes after the COVID positivity rate hit a 7-month low. “I absolutely believe COVID will continue to go down and vaccinations will go up,” the NYC mayor said.
Mayor de Blasio’s term ends this November, and he will not be running for reelection.
You can follow Jenny Goldsberry on Twitter @jennyjournalism.
Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:
The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.
“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”
“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.
The Daily Caller reports:
According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.
The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.
Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.
-
China5 days agoChinese Spy Balloon: Tensions rise between the U.S. and China
-
Environment21 hours agoMontana Senator censored, Twitter account suspended, for hunting photo
-
Podcast6 days agoDeep State Caught Waging Warfare Against the American People
-
Israel6 days agoDemocratic Rep. Ilhan Omar kicked off House Foreign Affairs Committee
